Alzheimer’s Disease and Mild Cognitive Impairment

Alzheimer’s Disease and Mild Cognitive Impairment

June 2009 – Vol 11 – No. 2

State of the art

Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention
Chengxuan Qiu, MD, PhD; Miia Kivipelto, MD, PhD; Eva von Strauss, PhD

Translational research

Novel strategies for the prevention of dementia from Alzheimer’s disease
Diana W. Shineman, PhD

Early detection of Alzheimer’s disease: new diagnostic criteria
Bruno Dubois, MD, PhD

Biological markers for early detection and pharmacological treatment of Alzheimer’s disease
Harald Hampel, MD, MA, MSc; Karl Broich, MD; Yvonne Hoessler, MA; Johannes Pantel, MD, PhD

Mechanism-based treatments for Alzheimer’s disease
Peter Davies, PhD

Basic research

Is there a neuropathology difference between mild cognitive impairment and dementia?
Vahram Haroutunian, PhD

Clinical research

Structural neuroimaging in Alzheimer’s disease: do white matter hyperintensities matter?
Adam M. Brickman, PhD; Jordan Muraskin, BS; Molly E. Zimmerman, PhD

Imaging in Alzheimer’s disease
Philip Scheltens , MD, PhD

The effects of cardiovascular risk factors on cognitive compromise
Michal Schnaider Beeri, PhD; Ramit Ravona-Springer, MD; Jeremy M. Silverman, PhD; Vahram Haroutunian, PhD

Is dementia preventable?
Amos D. Korczyn, MD; MSc

Family caregivers of people with dementia
Henry Brodaty, MD; DSc; FRACP; FRANZCP; Marika Donkin, BA-Psychology (Rons); Grad’DipProf Ethics